H. H. Schrenk

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.

G. Hartung, G. Stehle, H. Sinn et al. · PubMed · 1999 · 89 citations

Medicine, Oncology, Pharmacology +16

Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent

H. J. Sinn, H. H. Schrenk, E. Friedrich et al. · Analytical Biochemistry · 1988 · 80 citations

Life Sciences, Biochemistry, Metabolism +4

Enhanced albumin uptake by rat tumors

A. Wunder, G. Stehle, H. Sinn et al. · International Journal of Oncology · 1997 · 75 citations

Medicine, Nuclear Medicine, Oncology +14

Design of compounds having an enhanced tumour uptake, using serum albumin as a carrier. Part I

H. Sinn, H. H. Schrenk, E. Friedrich et al. · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · 1990 · 67 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Acute Response of Guinea Pigs to Vapors of Some New Commercial Organic Compounds II: Ethyl Benzene

W. P. Yant, H. H. Schrenk, Chris Waite et al. · Public Health Reports (1896-1970) · 1930 · 51 citations

Pharmacy, Toxicology, Organic Chemistry +10